Table of Content

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Historical Background
3.3. The Concept of Modular Facilities
3.3.1. Types of Modular Constructs
3.3.2. Modular Construction Process
3.4. Modular Construction in the Pharmaceutical Industry
3.4.1. Advantages of Modular Construction in the Pharmaceutical Industry
3.4.2. Modular Pharmaceutical Cleanrooms
3.4.2.1. Cleanroom Classifications and Current Standards
3.4.2.2. Regulations and Standards Concerning Modular Cleanroom Construction
3.5. Advantages of Modular Cleanrooms
3.6. Challenges and Future Prospects

4. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS
4.1. Chapter Overview
4.2. Modular Facility Manufacturers: Overall Market Landscape
4.2.1 Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Year of Establishment and Location of Headquarters
4.2.5. Analysis by Company Size and Location of Headquarters
4.2.6. Analysis by Type of Industry Served
4.2.7. Analysis by Geographical Coverage
4.2.8. Analysis by Type of Industry Served and Geographical Coverage
4.2.9. Analysis by GMP Compliance
4.2.10. Analysis by Geographical Coverage and GMP Compliance
4.2.11. Analysis by Type of Modular Construction
4.2.12. Analysis by Type of Industry Served and Type of Modular Construction
4.2.13. Analysis by Type of Material Used
4.2.14. Analysis by Type of Modular Construction and Type of Material Used
4.2.15. Analysis of Historical and Current Market Landscape Trends
4.2.15.1 Analysis by Company Size, Geographical Coverage and Type of Industry Served

5. MARKET LANDSCAPE: MODULAR CLEANROOM MANUFACTURERS
5.1. Chapter Overview
5.2. Modular Cleanroom Manufacturers: Overall Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Year of Establishment and Location of Headquarters
5.2.5. Analysis by Company Size and Location of Headquarters
5.2.6. Analysis by Type of Industry Served
5.2.7. Analysis by Location of Headquarters and Type of Industry Served
5.2.8. Analysis by Type of Modular Cleanroom Offered
5.2.9. Analysis by Type of Industry Served and Type of Modular Cleanroom Offered
5.2.10. Analysis by Type of Cleanroom Component Offered
5.2.11. Analysis by Type of Industry Served and Cleanroom Component Offered
5.2.12. Analysis by Type of Modular Cleanroom and Cleanroom Component Offered
5.2.13. Analysis by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
5.2.14. Analysis by Quality Certifications Obtained

6. MODULAR FACILITY MANUFACTURERS: COMPANY COMPETITIVENESS ANALYSIS
6.1 Chapter Overview
6.2 Assumptions / Key Parameters
6.3 Methodology
6.4 Company Competitiveness Analysis: Modular Facility Manufacturers
6.4.1. Company Competitiveness Analysis: Benchmarking of Service Strength
6.4.2. Company Competitiveness Analysis: Benchmarking of Partnership activity
6.4.3. Company Competitiveness Analysis: Small Companies
6.4.4. Company Competitiveness Analysis: Mid-Sized Companies
6.4.5. Company Competitiveness Analysis: Large Companies

7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Cytiva
7.2.1. Company Overview
7.2.2. Modular Facility-related Services
7.2.3. Modular Projects
7.2.4. Recent Developments and Future Outlook
7.3. G-Con Manufacturing
7.3.1. Company Overview
7.3.2. Modular Facility-related Services
7.3.3. Modular Projects
7.3.4. Recent Developments and Future Outlook
7.4. Germfree
7.4.1. Company Overview
7.4.2. Modular Facility-related Services
7.4.3. Modular Projects
7.4.4. Recent Developments and Future Outlook
7.5. IPM Technologies
7.5.1. Company Overview
7.5.2. Modular Facility-related Services
7.5.3. Modular Projects
7.5.4. Recent Developments and Future Outlook
7.6. KeyPlants
7.6.1. Company Overview
7.6.2. Modular Facility-related Services
7.6.3. Modular Projects
7.6.4. Recent Developments and Future Outlook
7.7. ModuleCo Pharma
7.7.1. Company Overview
7.7.2. Modular Facility-related Services
7.7.3. Modular Projects
7.7.4. Recent Developments and Future Outlook
7.8. NNE
7.8.1. Company Overview
7.8.2. Modular Facility-related Services
7.8.3. Modular Projects
7.8.4. Recent Developments and Future Outlook
7.9. Pharmadule
7.9.1. Company Overview
7.9.2. Modular Facility-related Services
7.9.3. Modular Projects
7.9.4. Recent Developments and Future Outlook

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Modular Facility Manufacturers: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year of Partnership and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Modular Facility
8.3.7. Analysis by Type of Product and Type of Modular Facility
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Location of Partner’s Headquarters
8.3.10. Analysis by Location of Modular Facility
8.3.11. Analysis by Type of Partnership and Location of Modular Facility
8.3.12. Analysis by Type of Product and Location of Modular Facility
8.3.13. Intercontinental and Intracontinental Partnerships
8.3.14. Analysis by Country

9. CASE STUDY ON MODULAR PROJECTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
9.1. Chapter Overview
9.2. Modular Versus Conventional Construction Methods
9.3. Return on Investment
9.4. Case Study: Facility Based on KUBio Platform
9.4.1. Cytiva KUBio Platform: Overview
9.4.2. Eden Biologics Kubio Modular Project in China: Overview and Construction Details
9.5. Modular Facility Projects Undertaken in the Pharmaceutical and Biotechnology Industry
9.5.1. Analysis by Type of Modular Facility
9.5.2. Analysis by Size of Modular Facility
9.5.3. Most Active Manufacturers: Analysis by Number of Projects Delivered
9.5.4. Leading Clients: Analysis by Number of Projects Received
9.5.5. Analysis by Location of Modular Facility
9.5.6. Analysis by Type of Facility and Size of Modular Facility
9.5.7. Analysis by Client and Location of Facility

10. FACILITY CONSTRUCTION TRENDS IN THE PHARMACEUTICAL INDUSTRY
10.1. Chapter Overview
10.2. Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry: Historical Data for Top 20 Players
10.2.1. Analysis by Number of Facilities Delivered
10.2.2. Analysis by Type of Facility
10.2.3. Analysis by Purpose of Facility
10.2.4. Analysis by Type of Facility and Purpose of Facility
10.2.5. Analysis by Type of Investment
10.2.6. Analysis by Purpose of Facility and Type of Investment
10.2.7. Analysis by Size of Facility
10.2.8. Analysis by Type of Facility and Size of Facility
10.2.9. Analysis by Purpose of Facility and Size of Facility
10.2.10. Analysis by Location of Headquarters
10.2.11. Analysis by Location of Facility
10.2.12. Analysis by Type of Facility and Location of Facility
11. COST-TIME OPTIMIZATION FRAMEWORK
11.1. Chapter Overview
11.2. Key Parameters
11.3. Key Assumptions and Methodology
11.4. Comparison of Intrinsic Factors
11.4.1. Analysis by Type of Material Used
11.4.2. Analysis by Type of Modular Construction
11.4.1. Analysis by Purpose of Facility
11.4.2. Analysis by Geographical Location
11.5. Integrated Outcome Modeling – Scenario Analysis
11.6. Integrated Outcome Modeling – Output Analysis
11.7. Concluding Remarks
12. MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Modular Construction Market in the Pharmaceutical / Biotechnology Sector, 2023-2035
12.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Size of Facility, 2023 and 2035
12.4.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Small Facilities, 2023-203
12.4.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mid-sized Facilities, 2023-2035
12.4.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Large Facilities, 2023-2035
12.4.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Very Large Facilities, 2023-2035
12.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Industry Served, 2023 and 2035
12.5.1. Modular Construction Market in the Pharmaceutical Industry, 2023-2035
12.5.2. Modular Construction Market in the Biotechnology Industry, 2023-2035
12.6. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Modular Construct, 2023 and 2035
12.6.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Hybrid Skid Modular Constructs, 2023-2035
12.6.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Skid-Mounted Modular Constructs, 2023-2035
12.6.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Plug-and-Play Modular Constructs, 2023-2035
12.6.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Truckable Modular Constructs, 2023-2035
12.6.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Modular Constructs, 2023-2035
12.7. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Construction Component, 2023 and 2035
12.7.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Equipment, 2023-2035
12.7.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Base Buildings, 2023-2035
12.7.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mechanical, Electrical and Plumbing Systems, 2023-2035
12.7.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Commodities, 2023-2035
12.7.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Construction Components, 2023-2035
12.8 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Purpose of Facility, 2023 and 2035
12.8.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Manufacturing, 2023-2035
12.8.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Aseptic Filling, 2023-2035
12.8.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Research and Development, 2023-2035
12.8.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Purposes, 2023-2035
12.9. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Scale of Operation, 2023 and 2035
12.9.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Clinical Scale, 2023-2035
12.9.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Commercial Scale, 2023-2035
12.10. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Product, 2023 and 2035
12.10.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Cell and Gene Therapies, 2023-2035
12.10.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Vaccines, 2023-2035
12.10.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Biosimilars, 2023-2035
12.10.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Monoclonal Antibodies, 2023-2035
12.10.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Advanced Pharmaceuticals, 2023-2035
12.10.6. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Sterile Products, 2023-2035
12.10.7. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Viral Vectors, 2023-2035
12.10.8. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Products, 2023-2035
12.11. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Facility, 2023 and 2035
12.11.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for New Facilities, 2023-2035
12.11.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Facility Expansions, 2023-2035
12.11.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Planned Expansions, 2023-2035
12.12. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Modular Construction, 2023 and 2035
12.12.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Relocatable Modular Construction, 2023-2035
12.12.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Permanent Modular Construction, 2023-2035
12.13. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Material Used, 2023 and 2035
12.13.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Steel, 2023-2035
12.13.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Wood, 2023-2035
12.13.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Concrete, 2023-2035
12.14. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Geography, 2023 and 2035
12.14.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in North America, 2023-2035
12.14.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Europe, 2023-2035
12.14.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Asia, 2023-2035
12.14.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Middle East and North Africa, 2023-2035
12.14.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Rest of the World, 2023-2035
12.15. Concluding Remarks

13. PREVALENT AND EMERGING INDUSTRY TRENDS
13.1. Chapter Overview
13.2. Adoption of Modular Facilities
13.3. Expansion of Existing Service Portfolio
13.4. Integration of Advanced Technologies
13.4.1. Single-use Technologies
13.4.2. Continuous Processing Technologies
13.4.3. Other Advanced Technologies

14. FUTURE GROWTH OPPORTUNITIES
14.1. Chapter Overview
14.2. Visibility Amongst Start-Ups
14.3. Popularity Amongst Contract Manufacturing Organizations
14.4. Expansion of Existing Facilities
14.5. Adoption for Production of Biosimilars
14.6. Additional Opportunities
14.7. Key Growth Drivers for Modular Construction
14.8. Market Attractiveness in Emerging regions

15. CONCLUSION

16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. Avon Modular
16.2.1. Company Snapshot
16.2.2. Interview Transcript
16.3. Environmental Systems Corporation
16.3.1. Company Snapshot
16.3.2. Interview Transcript
16.4. Exyte
16.4.1. Company Snapshot
16.4.2. Interview Transcript
16.5. G-Con Manufacturing
16.5.1. Company Snapshot
16.5.2. Interview Transcript
16.6. Modular Devices
16.6.1. Company Snapshot
16.6.2. Interview Transcript
16.7. ModWave
16.7.1. Company Snapshot
16.7.2. Interview Transcript
16.8. Subzero Engineering
16.8.1. Company Snapshot
16.8.2. Interview Transcript
16.9. Vernick
16.9.1. Company Snapshot
16.9.2. Interview Transcript
16.10. Zeton
16.10.1. Company Snapshot
16.10.2. Interview Transcript
17. APPENDIX I: TABULATED DATA
18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS